We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+11.36%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$67.2B
AUM Growth
+$10.7B
(+19%)
Cap. Flow
+$4.46B
Cap. Flow
% of AUM
6.63%
Top 10 Holdings %
Top 10 Hldgs %
6.15%
Holding
4,027
New
877
Increased
1,461
Reduced
1,084
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$474M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$357M |
| 3 |
Accenture
ACN
|
+$246M |
| 4 |
Advanced Micro Devices
AMD
|
+$235M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$375M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$348M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$292M |
| 5 |
Snowflake
SNOW
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.18% |
| 2 | Financials | 15.54% |
| 3 | Industrials | 10.51% |
| 4 | Healthcare | 9.8% |
| 5 | Consumer Discretionary | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Citius Pharmaceuticals
CTXR
$18.7M
| $27K | ﹤0.01% |
21,803
+8,929
| +69% | +$12.4K |
|
3502
NN Inc
NNBR
$311M
| $26.8K | ﹤0.01% |
+13,020
| New | +$29.2K |
|
3503
Strive Inc
ASST
$1.05B
| $26.8K | ﹤0.01% |
+535
| New | +$50.9K |
|
3504
NeuroSense Therapeutics
NRSN
$18M
| $26.4K | ﹤0.01% |
+21,086
| New | +$30.9K |
|
3505
Pasithea Therapeutics
KTTA
$16.9M
| $26.2K | ﹤0.01% |
+35,760
| New | +$26.1K |
|
3506
Theriva Biologics
TOVX
$10.1M
| $25.1K | ﹤0.01% |
+61,837
| New | +$26.8K |
|
|
TRIB
3507
Trinity Biotech
TRIB
$8.39M
| $24.9K | ﹤0.01% |
800
+298
| +59% | +$9.39K |
|
3508
GEE Group
JOB
$22.5M
| $24.9K | ﹤0.01% |
120,526
-3,427
| -3% | -$696 |
|
3509
Quince Therapeutics
QNCX
$29.5M
| $24.6K | ﹤0.01% |
75
-12
| -14% | -$4K |
|
3510
Battalion Oil
BATL
$28.8M
| $24.4K | ﹤0.01% |
+20,196
| New | +$24.7K |
|
|
ORGN
3511
DELISTED
Origin Materials
ORGN
| $24K | ﹤0.01% |
+1,542
| New | +$28.6K |
|
3512
Beneficient
BENF
$43.5M
| $22.6K | ﹤0.01% |
+2,971
| New | +$8.69K |
|
3513
Senti Biosciences Holdings
SNTI
$11M
| $22.5K | ﹤0.01% |
+15,968
| New | +$26.7K |
|
|
STAI
3514
DELISTED
ScanTech AI Systems
STAI
| $22.4K | ﹤0.01% |
2,703
-666
| -20% | -$7.28K |
|
|
IOTR
3515
iOThree Ltd
IOTR
$14M
| $22K | ﹤0.01% |
5,774
+1,988
| +53% | +$8.53K |
|
|
FFAI
3516
Faraday Future Intelligent Electric
FFAI
$10.5M
| $22K | ﹤0.01% |
113
-756
| -87% | -$239K |
|
|
ALLR
3517
Allarity Therapeutics
ALLR
$22.1M
| $22K | ﹤0.01% |
+13,910
| New | +$17.5K |
|
|
GORV
3518
DELISTED
Lazydays
GORV
| $21.8K | ﹤0.01% |
+10,470
| New | +$46.6K |
|
|
IBO
3519
Impact BioMedical
IBO
$46.9M
| $20.9K | ﹤0.01% |
31,500
+8,800
| +39% | +$5.55K |
|
|
RPTX
3520
DELISTED
Repare Therapeutics
RPTX
| $19.3K | ﹤0.01% |
10,967
-21,288
| -66% | -$34.1K |
|
|
AIFA
3521
All In FutureTech Alliance Inc
AIFA
$12.8M
| $19.1K | ﹤0.01% |
+3,463
| New | +$29.3K |
|
3522
Kaltura
KLTR
$267M
| $18.1K | ﹤0.01% |
12,583
-56,520
| -82% | -$95.3K |
|
|
GRML
3523
Greenland Mines Ltd
GRML
$29.2M
| $17.7K | ﹤0.01% |
+36,571
| New | +$31.7K |
|
3524
iPower
IPW
$780K
| $17.1K | ﹤0.01% |
15
+8
| +114% | +$10.2K |
|
3525
Myomo
MYO
$56.2M
| $16.9K | ﹤0.01% |
18,890
-132,865
| -88% | -$193K |
|
Similar funds
VAM
Two Sigma Investments's Q3 2025 Portfolio in Review
As of Q3 2025, Two Sigma Investments held 4,027 positions worth $67.2B, up 19% from $56.5B the previous quarter. Its ten largest holdings account for 6.2% of the portfolio.
Two Sigma Investments deployed $4.46B of net new capital in Q3 2025, opening 877 new positions and adding to 1,461 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 379,096 shares worth $191M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $381M trimmed.
- Two Sigma Investments's largest Q3 2025 buy was Berkshire Hathaway Class B: 379,096 shares worth $191M.
- Two Sigma Investments added most to State Street Financial Select Sector SPDR ETF in Q3 2025, an estimated $474M increase.
- Two Sigma Investments's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $381M.
- Two Sigma Investments fully exited NextEra Energy, Inc. 6.926% Corporate Units in Q3 2025, selling an estimated $115M.
- Two Sigma Investments's ten largest holdings make up 6.2% of its $67.2B portfolio in Q3 2025.
- Two Sigma Investments opened 877 new positions and closed 399 in Q3 2025.
- Two Sigma Investments's portfolio value rose 19% quarter-over-quarter to $67.2B.
Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.